Neoadjuvant Systemic Therapy for Breast Cancer Searching for More Effectively Curative Therapies

被引：4
|
作者：
Sparano, Joseph A. [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, 1695 Eastchester Rd, Bronx, NY 10461 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 03期
基金：
美国国家卫生研究院;
关键词：
PHASE-3; TRIAL; DRUG APPROVAL; OPEN-LABEL; TRASTUZUMAB; MULTICENTER; PERTUZUMAB; LAPATINIB;
D O I：
10.1001/jamaoncol.2017.4651
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：293 / 295
页数：3
相关论文
共 50 条
  • [21] Biomarker evolution after neoadjuvant systemic therapy in breast cancer.
    Castillo, Dan Ran
    Pairawan, Seyed Saeed
    Denham, Laura
    Lum, Sharon S.
    Nagaraj, Gayathri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals
    Mamounas, Eleftherios
    Poulos, Christine
    Goertz, Hans-Peter
    Gonzalez, Juan Marcos
    Pugh, Amy
    Antao, Vincent
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3510 - 3517
  • [23] Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons’ Referrals
    Eleftherios Mamounas
    Christine Poulos
    Hans-Peter Goertz
    Juan Marcos González
    Amy Pugh
    Vincent Antao
    [J]. Annals of Surgical Oncology, 2016, 23 : 3510 - 3517
  • [24] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    A. Eniu
    [J]. memo - Magazine of European Medical Oncology, 2008, 1 (3) : 143 - 147
  • [25] Metaplastic Breast Cancer Has a Poor Response to Neoadjuvant Systemic Therapy
    Al-Hilli, Zahraa
    Jakub, James
    Visscher, Daniel
    Ingle, James
    Goetz, Matthew
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 24 - 25
  • [26] Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
    Zahraa Al-Hilli
    Grace Choong
    Michael G. Keeney
    Daniel W. Visscher
    James N. Ingle
    Matthew P. Goetz
    James W. Jakub
    [J]. Breast Cancer Research and Treatment, 2019, 176 : 709 - 716
  • [27] Can we tailor neoadjuvant (primary) systemic therapy for breast cancer?
    Eniu, A.
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (03) : 143 - 147
  • [28] Surgical considerations for breast cancer patients receiving neoadjuvant systemic therapy
    Hunt, Kelly K.
    Mittendorf, Elizabeth A.
    [J]. BREAST CANCER MANAGEMENT, 2013, 2 (05) : 385 - 395
  • [29] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    S. Di Cosimo
    C. Depretto
    R. Miceli
    P. Baili
    S. Ljevar
    M. Sant
    V. Cappelletti
    S. Folli
    M. Gennaro
    F. G. De Braud
    G. Bianchi
    A. Vingiani
    G. Pruneri
    A. Marchianò
    E. La Rocca
    M. C. De Santis
    G. P. Scaperrotta
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 775 - 781
  • [30] Controversies Concerning the Use of Neoadjuvant Systemic Therapy for Primary Breast Cancer
    Manfred Kaufmann
    Thomas Karn
    Eugen Ruckhäberle
    [J]. World Journal of Surgery, 2012, 36 : 1480 - 1485
12345